Literature DB >> 7533604

Normal sweat chloride values do not exclude the diagnosis of cystic fibrosis.

B Stewart1, J Zabner, A P Shuber, M J Welsh, P B McCray.   

Abstract

Since its introduction in 1959, the sweat test has remained the "gold standard" diagnostic test for cystic fibrosis (CF). It is apparent that CF encompasses a wide spectrum of disease, from meconium ileus and severe respiratory compromise in infants to the presentation of mild pulmonary symptoms and no evidence of gastrointestinal disease in adults. In patients with lung disease that might otherwise be consistent with CF, normal sweat chloride (Cl-) values have tended to exclude the diagnosis. In this report we describe two patients from two families with the compound heterozygotic CF mutations delta F508/3849 + 10 kb C-->T. These patients had mild manifestations of disease, including clinical pancreatic sufficiency (normal growth without pancreatic enzyme supplementation) and absence of azoospermia. Sweat Cl- values were in the normal range. However, both patients developed bronchiectasis, progressive obstructive lung disease, and colonization with Pseudomonas. The diagnosis of CF was made using nasal transepithelial voltage measurements and genotyping. These cases emphasize the need to maintain a high index of suspicion of CF in atypical cases, and to pursue alternative diagnostic tests to confirm a diagnosis of CF suspected on clinical grounds, despite normal sweat test results.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7533604     DOI: 10.1164/ajrccm/151.3_Pt_1.899

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  13 in total

1.  Australian guidelines for the performance of the sweat test for the diagnosis of cystic fibrosis: report from the AACB Sweat Testing Working Party.

Authors:  John Coakley; Sue Scott; James Doery; Ronda Greaves; Peter Talsma; Elaine Whitham; Janet Winship
Journal:  Clin Biochem Rev       Date:  2006-05

Review 2.  Diagnosing cystic fibrosis: blood, sweat, and tears.

Authors:  C Wallis
Journal:  Arch Dis Child       Date:  1997-02       Impact factor: 3.791

3.  Effects of gender and age at diagnosis on disease progression in long-term survivors of cystic fibrosis.

Authors:  Jerry A Nick; Cathy S Chacon; Sara J Brayshaw; Marion C Jones; Christine M Barboa; Connie G St Clair; Robert L Young; David P Nichols; Jennifer S Janssen; Gwen A Huitt; Michael D Iseman; Charles L Daley; Jennifer L Taylor-Cousar; Frank J Accurso; Milene T Saavedra; Marci K Sontag
Journal:  Am J Respir Crit Care Med       Date:  2010-05-06       Impact factor: 21.405

4.  The relevance of sweat testing for the diagnosis of cystic fibrosis in the genomic era.

Authors:  Avantika Mishra; Ronda Greaves; John Massie
Journal:  Clin Biochem Rev       Date:  2005-11

5.  Cystic fibrosis in Korean children:a case report identified by a quantitative pilocarpine iontophoresis sweat test and genetic analysis.

Authors:  Kang Mo Ahn; Hwa Young Park; Ji Hyun Lee; Min Goo Lee; Jeong Ho Kim; Im Ju Kang; Sang Il Lee
Journal:  J Korean Med Sci       Date:  2005-02       Impact factor: 2.153

6.  Phenotypes of California CF Newborn Screen-Positive Children with CFTR 5T Allele by TG Repeat Length.

Authors:  Danieli Barino Salinas; Colleen Azen; Suzanne Young; Thomas G Keens; Martin Kharrazi; Richard B Parad
Journal:  Genet Test Mol Biomarkers       Date:  2016-07-22

Review 7.  Cystic fibrosis.

Authors:  Felix Ratjen; Scott C Bell; Steven M Rowe; Christopher H Goss; Alexandra L Quittner; Andrew Bush
Journal:  Nat Rev Dis Primers       Date:  2015-05-14       Impact factor: 52.329

8.  Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report.

Authors:  Philip M Farrell; Beryl J Rosenstein; Terry B White; Frank J Accurso; Carlo Castellani; Garry R Cutting; Peter R Durie; Vicky A Legrys; John Massie; Richard B Parad; Michael J Rock; Preston W Campbell
Journal:  J Pediatr       Date:  2008-08       Impact factor: 4.406

9.  Aquagenic Wrinkling of the Palm: A Rare Diagnostic Clue of Cystic Fibrosis and the Response to CFTR-Modulating Therapy.

Authors:  Paola M Torres-Laboy; Jesus M Melendez-Montañez; Wilfredo De Jesús-Rojas
Journal:  Cureus       Date:  2021-04-11

10.  Defective CFTR expression and function are detectable in blood monocytes: development of a new blood test for cystic fibrosis.

Authors:  Claudio Sorio; Mario Buffelli; Chiara Angiari; Michele Ettorre; Jan Johansson; Marzia Vezzalini; Laura Viviani; Mario Ricciardi; Genny Verzè; Baroukh Maurice Assael; Paola Melotti
Journal:  PLoS One       Date:  2011-07-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.